Arkolith/Insider Trading/BMEA/Form 4/A

A2A Pharmaceuticals, Inc.

10% OwnerBiomea Fusion, Inc. (BMEA) · full profile →Form 4/A · filed Apr 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.3M
Net Open-Market Flow
-$6.3M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2023Sell(S)200K$31.25$6.3M4.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001859061-23-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML